RBF Capital’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Sell
218,714
-6,286
-3% -$39.1K 0.07% 238
2025
Q4
$1.29M Hold
225,000
0.06% 259
2025
Q3
$1.53M Hold
225,000
0.07% 239
2025
Q2
$2.02M Buy
+225,000
New +$1.33M 0.1% 199

Other funds holding ULBI

RBF Capital's ULBI Position: Q1 2026 in Review

RBF Capital reduced its Ultralife (ULBI) stake by 2.8% in Q1 2026, selling an estimated $39.1K and leaving 218,714 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #238.

RBF Capital first reported a position in ULBI in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.02M in Q2 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • RBF Capital held 218,714 shares of Ultralife worth $1.43M as of Q1 2026.
  • RBF Capital sold 6,286 Ultralife shares in Q1 2026, an estimated $39.1K.
  • Ultralife made up 0.07% of RBF Capital's portfolio in Q1 2026, its #238 holding.
  • RBF Capital first reported a position in Ultralife in Q2 2025 and has held it in 4 quarters since.
  • RBF Capital's Ultralife position peaked at $2.02M in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.